These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27690486)

  • 41. Misadventures in insulin therapy: are you at risk?
    Grissinger M; Lease M
    J Natl Med Assoc; 2003 Feb; 95(2 Suppl 1):1S-16S. PubMed ID: 12653373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Barriers to Remote Health Interventions for Type 2 Diabetes: A Systematic Review and Proposed Classification Scheme.
    Alvarado MM; Kum HC; Gonzalez Coronado K; Foster MJ; Ortega P; Lawley MA
    J Med Internet Res; 2017 Feb; 19(2):e28. PubMed ID: 28193598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What Matters Most. People weigh in on why they use their diabetes management products.
    Wahowiak L
    Diabetes Forecast; 2016; 69(2):46-9. PubMed ID: 27048048
    [No Abstract]   [Full Text] [Related]  

  • 44. Mobile phone technologies and advanced data analysis towards the enhancement of diabetes self-management.
    Kouris I; Mougiakakou S; Scarnato L; Iliopoulou D; Diem P; Vazeou A; Koutsouris D
    Int J Electron Healthc; 2010; 5(4):386-402. PubMed ID: 21041177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy.
    Combs CA
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2025-7. PubMed ID: 22384837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes technologies - what the general physician needs to know.
    Li A; Hussain S
    Clin Med (Lond); 2020 Sep; 20(5):469-476. PubMed ID: 32934039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients.
    Kollmann A; Riedl M; Kastner P; Schreier G; Ludvik B
    J Med Internet Res; 2007 Dec; 9(5):e36. PubMed ID: 18166525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist.
    Hirsch IB
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2232-8. PubMed ID: 19383778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Position statement on efficiency of technologies for diabetes management.
    Martín-Vaquero P; Martínez-Brocca MA; García-López JM; ; ;
    Endocrinol Nutr; 2014 Dec; 61(10):e45-63. PubMed ID: 25453400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychosocial aspects of diabetes technology.
    Kubiak T; Priesterroth L; Barnard-Kelly KD
    Diabet Med; 2020 Mar; 37(3):448-454. PubMed ID: 31943354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes Technology.
    Pfützner A
    Endocr Dev; 2016; 31():57-83. PubMed ID: 26824436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform.
    Irace C; Acmet E; Cutruzzolà A; Parise M; Ponzani P; Scarpitta AM; Candido R
    Endocrine; 2024 May; 84(2):441-449. PubMed ID: 37996773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes Educators' Intended and Reported Use of Common Diabetes-Related Technologies: Discrepancies and Dissonance.
    James S; Perry L; Gallagher R; Lowe J
    J Diabetes Sci Technol; 2016 Nov; 10(6):1277-1286. PubMed ID: 27179011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines.
    Chomutare T; Fernandez-Luque L; Arsand E; Hartvigsen G
    J Med Internet Res; 2011 Sep; 13(3):e65. PubMed ID: 21979293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New technology and diabetes management.
    Kowalski A
    Am J Nurs; 2007 Jun; 107(6 Suppl):16-7. PubMed ID: 17563427
    [No Abstract]   [Full Text] [Related]  

  • 58. Patient tips from industry. Benefits of pump therapy.
    Diabetes Educ; 2004; 30(2):257. PubMed ID: 15095515
    [No Abstract]   [Full Text] [Related]  

  • 59. Outcomes of a feasibility trial using an innovative mobile health programme to assist in insulin dose adjustment.
    Menon A; Fatehi F; Ding H; Bird D; Karunanithi M; Gray L; Russell A
    BMJ Health Care Inform; 2019 Oct; 26(1):. PubMed ID: 31676495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy.
    Schiaffini R; Tagliente I; Carducci C; Ullmann N; Ciampalini P; Lorubbio A; Cappa M
    J Telemed Telecare; 2016 Jul; 22(5):277-81. PubMed ID: 26289613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.